SureTrader Nadex Advertisement SureTrader
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board: 
Last Post: 4/29/2017 5:07:56 AM - Followers: 1326 - Board type: Free - Posts Today: 1

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
Recent Biotech Buyouts
Buyouts of Biotech Partners
FoB Collaborations

Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#210976  Sticky Note NTRP—(+12%)—CC Monday for phase-2 data in ADI never mcbio 04/28/17 02:56:07 PM
#210964  Sticky Note FDA approves RDUS osteoporosis drug • Radius Health (RDUS lgonber 04/28/17 11:28:57 AM
#210959  Sticky Note Novartis-- The U.S. Food and Drug Administration today approved puravida 04/28/17 10:33:39 AM
#210932  Sticky Note CMC is a sort of universal "gotcha" for DewDiligence 04/27/17 04:08:05 PM
#210904  Sticky Note Digging up this old AKBA post because it biomaven0 04/27/17 10:23:08 AM
#210691  Sticky Note MNTA—Interchangeable Humira FoB for US market is badly needed: DewDiligence 04/18/17 03:36:02 PM
#210983   TGTX: data was good, wasn't it? Is that lgonber 04/29/17 05:07:56 AM
#210982   I wonder if you can make an antitrust biomaven0 04/28/17 04:54:32 PM
#210981   TRXC -41% on warrant-laden financing: DewDiligence 04/28/17 04:39:19 PM
#210980   Absolutely. ABBV acknowledges that. DewDiligence 04/28/17 04:36:35 PM
#210979   >>Humira pricing biomaven0 04/28/17 04:32:11 PM
#210978   Today shows how biotech stocks can be defensive. GrthzGd 04/28/17 04:18:15 PM
#210977   TGTX -7% on interim phase-2 MS data reported DewDiligence 04/28/17 03:08:45 PM
#210976   NTRP—(+12%)—CC Monday for phase-2 data in ADI never mcbio 04/28/17 02:56:07 PM
#210975   Excellent! puravida 04/28/17 02:50:56 PM
#210974   FDA approves Brigatinib for second-line ALK+ NSCLC: DewDiligence 04/28/17 02:50:09 PM
#210973   Great post ...thx for the DD Whalatane 04/28/17 02:28:41 PM
#210972   ZBH hammered yesterday on reduction in upper bound DewDiligence 04/28/17 01:27:50 PM
#210971   SNY is #3 in China drug sales, BTW. DewDiligence 04/28/17 01:17:31 PM
#210970   SNY/REGN—FDA accepts resubmitted Kevzara (sarilumab) BLA for review: DewDiligence 04/28/17 01:02:49 PM
#210969   NTRP—(+12%)—CC Monday for phase-2 data in AD: DewDiligence 04/28/17 12:56:23 PM
#210968   CYTR—(-23%)—sells 30.0M shares @$0.50—a 26% discount to yesterday’s close: DewDiligence 04/28/17 12:49:37 PM
#210967   PLSE well if you find the time Whalatane 04/28/17 12:49:26 PM
#210966   China approves BMY 2-DAA HCV regimen for GT1b: DewDiligence 04/28/17 11:32:54 AM
#210965   He got involved in PCYC and invested a rkrw 04/28/17 11:31:24 AM
#210964   FDA approves RDUS osteoporosis drug • Radius Health (RDUS lgonber 04/28/17 11:28:57 AM
#210963   PLSE seems more reminiscent of Whalatane 04/28/17 11:24:26 AM
#210960   I have laughed many many (many) times at dwarren428 04/28/17 10:43:27 AM
#210959   Novartis-- The U.S. Food and Drug Administration today approved puravida 04/28/17 10:33:39 AM
#210958   [OT] Hi Dew, Its still working for me seschm 04/28/17 10:16:26 AM
#210956   Reminds of a professional biotech investor a few rkrw 04/28/17 08:41:29 AM
#210953   re: IMUN bladerunner1717 04/28/17 03:11:01 AM
#210952   $IMUN will be the next multi bagger biotech dwarren428 04/27/17 11:48:02 PM
#210951   fwiw Duggan got quite lucky with Pharmacyclics. He rkrw 04/27/17 11:29:43 PM
#210950   PLSE Robert Duggan adds to his position Whalatane 04/27/17 10:59:04 PM
#210949   AKBA FGEN GSK and PHD Inhibitors: iwfal 04/27/17 10:22:22 PM
#210948   Plantar-fasciitis - I had that long ago (BI=before zipjet 04/27/17 08:44:42 PM
#210947   AGN and RVNC will likely end up cross-licensing DewDiligence 04/27/17 08:17:06 PM
#210946   It'll be interesting to see how they work jbog 04/27/17 07:04:15 PM
#210945   RVNC’s plantar-fasciitis program is fine—see reply from CFO DewDiligence 04/27/17 06:53:03 PM
#210944   Roche discontinues ARN-810 (a/k/a RG6046) acquired in 2014 DewDiligence 04/27/17 06:01:57 PM
#210942   [RVNC] plantar fasciitis P2 terminated? WorstLuck 04/27/17 05:37:41 PM
#210941   [OT]—Thanks, Idit, but that one will probably go DewDiligence 04/27/17 05:31:08 PM
#210940   [OT]—The "uk" workaround to pull up the old genisi 04/27/17 05:25:21 PM
#210939   BMY +4% on 1Q17 results/raised 2017 guidance: DewDiligence 04/27/17 05:22:49 PM
#210938   For AZN, it’s MYSTIC or…cut bait: DewDiligence 04/27/17 05:15:35 PM
#210937   Clinical-trial sites in Eastern Europe can be problematic, DewDiligence 04/27/17 05:11:33 PM
#210936   EXAS—(+27%)—raised 2017 guidance big-league: DewDiligence 04/27/17 05:01:59 PM
#210935   [OT]—The "sg" workaround to pull up the old DewDiligence 04/27/17 04:51:21 PM
#210934   SNG.L -49% on AZN’s termination of AZD9412 program: DewDiligence 04/27/17 04:34:31 PM
#210933   TEVA—What do you make of this lawsuit? I DewDiligence 04/27/17 04:29:22 PM
#210932   CMC is a sort of universal "gotcha" for DewDiligence 04/27/17 04:08:05 PM
#210931   [OT]—it is possible to make multiple cash entries, DewDiligence 04/27/17 04:04:17 PM
#210930   Exact Sciences is also acquiring MDxHealth patents directed DewDiligence 04/27/17 03:58:14 PM
#210929   MDxHealth and EXAS Sign Collaboration Agreement Titan V 04/27/17 03:53:22 PM
#210927   ADXS does issue some cheesy PRs; they just DewDiligence 04/27/17 03:25:12 PM
PostSubject